Narwaney Komal J, Breslin Kristin, Ross Colleen A, Shoup Jo Ann, Wain Kris F, Weintraub Eric S, McNeil Michael M, Hambidge Simon J
Institute for Health Research, Kaiser Permanente Colorado, United States.
Ambulatory Care Services, Denver Health, United States.
Vaccine. 2017 Mar 1;35(9):1335-1340. doi: 10.1016/j.vaccine.2017.01.017. Epub 2017 Feb 6.
The Institute of Medicine, in a 2013 report, recommended that the Vaccine Safety Datalink (VSD) expand collaborations to include more diversity in the study population. Kaiser Permanente Colorado (KPCO), an established VSD site, partnered with Denver Health (DH), an integrated safety net healthcare system, to demonstrate the feasibility of integrating DH data within the VSD. Prior to incorporating the data, we examined the identification of specific vaccine associated adverse events (VAEs) in these two distinct healthcare systems.
We conducted retrospective cohort analyses within KPCO and DH to compare select VAEs between the two populations. We examined the following associations between January 1, 2004 and December 31, 2013: Measles, Mumps, and Rubella (MMR) vaccine and febrile seizures in children 2years and younger, intussusception after rotavirus vaccine in infants 4-34weeks, syncope after adolescent vaccines (Tetanus, Diphtheria, acellular Pertussis; Meningococcal and Human Papillomavirus) in adolescents 13-17years and medically attended local reactions after pneumococcal polysaccharide (PPSV23) vaccine in adults 65years and older. Both sites used similar data procurement methods and chart review processes.
For seizures after MMR vaccine (KPCO - 3.15vs. DH - 2.97/10,000 doses) and syncope after all adolescent vaccines (KPCO - 3.0vs. DH - 2.37/10,000 doses), the chart confirmed rates were comparable at the two sites. However, for medically attended local reactions after PPSV23, there were differences in chart confirmed rates between the sites (KPCO - 31.65vs. DH - 14.90/10,000 doses). For intussusception after rotavirus vaccine, the number of cases was too low to make a valid comparison (KPCO - 0vs. DH - 0.13/10,000 doses).
We demonstrated that data on important targeted VAEs can be captured at DH and rates appear similar to those at KPCO. Work is ongoing on the optimal approach to assimilate DH data as a potential safety net healthcare system in the VSD.
医学研究所在2013年的一份报告中建议,疫苗安全数据链(VSD)应扩大合作,使研究人群更具多样性。科罗拉多州凯撒医疗机构(KPCO)作为VSD的一个既有站点,与丹佛健康中心(DH)合作,后者是一个综合性安全网医疗系统,旨在证明将DH的数据整合到VSD中的可行性。在纳入数据之前,我们研究了这两个不同医疗系统中特定疫苗相关不良事件(VAE)的识别情况。
我们在KPCO和DH内部进行了回顾性队列分析,以比较两个人群中选定的VAE。我们研究了2004年1月1日至2013年12月31日期间的以下关联:2岁及以下儿童的麻疹、腮腺炎和风疹(MMR)疫苗与热性惊厥;4至34周龄婴儿轮状病毒疫苗接种后的肠套叠;13至17岁青少年接种青少年疫苗(破伤风、白喉、无细胞百日咳;脑膜炎球菌和人乳头瘤病毒)后的晕厥;65岁及以上成年人接种肺炎球菌多糖(PPSV23)疫苗后的就医局部反应。两个站点都采用了类似的数据获取方法和图表审查流程。
对于MMR疫苗接种后的惊厥(KPCO - 3.15对DH - 2.97/10000剂)以及所有青少年疫苗接种后的晕厥(KPCO - 3.0对DH - 2.37/10000剂),两个站点的图表确认率相当。然而,对于PPSV23接种后的就医局部反应,两个站点的图表确认率存在差异(KPCO - 31.65对DH - 14.90/10000剂)。对于轮状病毒疫苗接种后的肠套叠,病例数过少,无法进行有效比较(KPCO - 0对DH - 0.13/10000剂)。
我们证明了在DH能够获取重要目标VAE的数据,且发生率似乎与KPCO相似。目前正在研究将DH数据纳入VSD作为潜在安全网医疗系统的最佳方法。